The novel viper FETUA-3 protein evolved a unique mode of inhibiting snake venom metalloproteinases
- 1University of Maryland at College Park: University of Maryland
Abstract
Molecular innovation and coevolution play major roles in the evolution of biological diversity, yet we have relatively few instances in which we understand the biological and molecular bases of coevolution. Rattlesnakes and other vipers have evolved resistance to their own novel venom metalloproteinase (MP) toxins through the invention and coevolution of serum-borne inhibitors (FETUAs) derived from the ancestral, non-inhibitory, serum glycoprotein Fetuin-A. However, how FETUAs acquired their function and their mechanism of action are unknown. Here, we use a combination of structure prediction, site-directed mutagenesis, functional analyses, and molecular dynamics to elucidate how the rattlesnake FETUA-3 protein evolved to inhibit three classes of venom MP toxins. We show that FETUA-3 uses a combination of structural motifs to bind multiple MPs with high-affinity and acts as a potent noncompetitive inhibitor by inserting its N-terminus into MP active sites and directly disrupting substrate cleavage. We also find strong selective constraints on key N-terminal residues that maintain FETUA-3 specificity for multiple MP targets. These results reveal that FETUA-3 evolved a unique mechanism of action distinct from other vertebrate metalloproteinase inhibitors and how a small number of FETUA proteins controls the activities of a large family of venom toxins.
Related
- Polymorphic Structures of an Artificial Nucleocapsid Evolved from a Circularly Permuted Bacterial Protein Cage
- Unique and novel methanotroph taxa from the tropics: taxonomic novelty and a gateway to methane mitigation and valorization applications
- P2' Site Scanning of Snake Kunitz-Type Toxin Analogue BF9-N17H with Unique P1 Site Histidine Highlights Novel XIa Inhibitory Peptides Without Plasmin Inhibitory Activity.
- Genetic, biochemical, and structural characterization of a novel KLUS subgroup of CTX-M-type extended-spectrum β-lactamases reveals an evolutionarily distinct lineage with unique functional properties
- Editorial Note: C4b Binding Protein Binds to CD154 Preventing CD40 Mediated Cholangiocyte Apoptosis: A Novel Link between Complement and Epithelial Cell Survival
BibTeX
@misc{dowell2026novel,
title = {{The novel viper FETUA-3 protein evolved a unique mode of inhibiting snake venom metalloproteinases}},
author = {N. L. Dowell and S. Vazquez-Torres and F. P. Ukken and M. Andjelkovic and M. Hajra and E. Cahill and B. Höcker and R. Fernandez-Leiro and S. Carroll},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.24.752146},
url = {https://www.biorxiv.org/content/10.64898/2026.09.24.752146v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - The novel viper FETUA-3 protein evolved a unique mode of inhibiting snake venom metalloproteinases
AU - N. L. Dowell
AU - S. Vazquez-Torres
AU - F. P. Ukken
AU - M. Andjelkovic
AU - M. Hajra
AU - E. Cahill
AU - B. Höcker
AU - R. Fernandez-Leiro
AU - S. Carroll
PY - 2026
DA - 2026/09/24
PB - bioRxiv
DO - 10.64898/2026.09.24.752146
UR - https://www.biorxiv.org/content/10.64898/2026.09.24.752146v1
AB - Molecular innovation and coevolution play major roles in the evolution of biological diversity, yet we have relatively few instances in which we understand the biological and molecular bases of coevolution. Rattlesnakes and other vipers have evolved resistance to their own novel venom metalloproteinase (MP) toxins through the invention and coevolution of serum-borne inhibitors (FETUAs) derived from the ancestral, non-inhibitory, serum glycoprotein Fetuin-A. However, how FETUAs acquired their function and their mechanism of action are unknown. Here, we use a combination of structure prediction, site-directed mutagenesis, functional analyses, and molecular dynamics to elucidate how the rattlesnake FETUA-3 protein evolved to inhibit three classes of venom MP toxins. We show that FETUA-3 uses a combination of structural motifs to bind multiple MPs with high-affinity and acts as a potent noncompetitive inhibitor by inserting its N-terminus into MP active sites and directly disrupting substrate cleavage. We also find strong selective constraints on key N-terminal residues that maintain FETUA-3 specificity for multiple MP targets. These results reveal that FETUA-3 evolved a unique mechanism of action distinct from other vertebrate metalloproteinase inhibitors and how a small number of FETUA proteins controls the activities of a large family of venom toxins.
ER -